{"status": "OK", "response": {"docs": [{"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: I do not approve of the direct marketing of medications to patients (front page, Feb. 17), but there could be a beneficial effect. Patients with severe mental illnesses like schizophrenia, manic-depression and Alzheimer's are notoriously noncompliant with treatment.", "headline": {"main": "Why Drug Makers Court Consumers; Ad's Side Effect"}, "abstract": "Dr Jeffrey A Lieberman letter says he does not approve of direct marketing of medications to mental patients, but advertising could also improve compliance", "print_page": "10", "word_count": 98, "_id": "4fd1de0f8eb7c8105d72199a", "snippet": "To the Editor:    I do not approve of the direct marketing of medications to patients (front page, Feb. 17), but there could be a beneficial effect. Patients with severe mental illnesses like schizophrenia, manic-depression and Alzheimer's are...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/21/opinion/l-why-drug-makers-court-consumers-ad-s-side-effect-690341.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LIEBERMAN, JEFFREY A"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}], "byline": null, "document_type": "article", "pub_date": "1998-02-21T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Statistics", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "SmithKline Beecham P.L.C. reported an 8.9 percent gain in fourth-quarter earnings yesterday despite the strong British pound, which may have hurt new-product sales by the large London-based drug maker. The company has attracted global attention in recent weeks with two potential mergers, first with American Home Products, subsequently dropped, and now with its British rival Glaxo Wellcome P.L.C. A SmithKline-Glaxo merger would create the largest drug company, with sales of $27 billion. Since announcing merger talks Jan. 30, both companies had been silent. That changed yesterday when Jan Leschly, SmithKline's chief executive, said an announcement about the Glaxo merger would come in early March.", "headline": {"main": "SmithKline Beecham's Net Increases 8.9% in Quarter", "kicker": "COMPANY REPORTS"}, "abstract": "Smithkline Beecham PLC reports 8.9 percent gain in fourth-quarter earnings; company earned 315 million pounds, or $525 million, for quarter, up from 299 million pounds a year earlier; Smithkline's chief executive Jan Leschly says announcement about Glaxo Wellcome PLC's merger will come in early March; chart (M)", "print_page": "2", "word_count": 770, "_id": "4fd20aed8eb7c8105d7788bd", "snippet": "SmithKline Beecham P.L.C. reported an 8.9 percent gain in fourth-quarter earnings yesterday despite the strong British pound, which may have hurt new-product sales by the large London-based drug maker.    The company has attracted global attention in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/18/business/company-reports-smithkline-beecham-s-net-increases-8.9-in-quarter.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LESCHLY, JAN"}, {"name": "organizations", "value": "GLAXO WELLCOME PLC"}, {"name": "organizations", "value": "SMITHKLINE BEECHAM PLC"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "COMPANY REPORTS"}], "byline": {"person": [{"firstname": "David", "middlename": "J.", "lastname": "MORROW", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID J. MORROW"}, "document_type": "article", "pub_date": "1998-02-18T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine Desk", "lead_paragraph": "The radio was on in the background the other day, low volume as usual, when I found myself inclining toward vaguely familiar music. It was something I had once known very well, and as I began to listen more intently, a few swells of melody pushed a button somewhere in my brainpan: Gershwin. The overture to ''Of Thee I Sing.'' I hadn't heard that music in about 30 years, but way back then I heard it a lot, during weeks of rehearsals for the high-school musical. Hearing the overture, I remembered the words of songs I hadn't sung in decades, as well as the one line I was entrusted to utter in the play -- ''Does the President live here all year round?'' I even remembered the mischievous arch in my friend Chuck's eyebrows as he gestured to me to sneak outside for a smoke. I could still point out the tree we hid behind.", "headline": {"main": "Our Memories, Our Selves"}, "abstract": "Stephen S Hall article on nature of memory and implications of quest for memory-enhancing drugs; notes diverse group of researchers have made spectacular progress on cellular and genetic front, laying groundwork for pharmaceutical manipulation of memory; notes most researchers and drug companies cite use of cognitive enhancers in treating Alzheimer's disease and other age-related dementia to quiet concerns about ethical implications of use of drugs on normal people; photos; drawings (L)", "print_page": "26", "word_count": 7246, "_id": "4fd20ae88eb7c8105d778452", "snippet": "The radio was on in the background the other day, low volume as usual, when I found myself inclining toward vaguely familiar music. It was something I had once known very well, and as I began to listen more intently, a few swells of melody pushed a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/15/magazine/our-memories-our-selves.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEMORY"}, {"name": "subject", "value": "ALZHEIMER'S DISEASE"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"firstname": "Stephen", "middlename": "S.", "lastname": "Hall", "rank": 1, "role": "reported", "organization": ""}], "original": "By Stephen S. Hall"}, "document_type": "article", "pub_date": "1998-02-15T00:00:00Z", "section_name": "Health; Magazine"}], "meta": {"hits": 3, "offset": 0, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}